<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Научные результаты биомедицинских исследований</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2658-6533-2021-7-2-0-1</article-id><article-id pub-id-type="publisher-id">2384</article-id><article-categories><subj-group subj-group-type="heading"><subject>Генетика</subject></subj-group></article-categories><title-group><article-title>&lt;strong&gt;Association of VEGFA, factor V and prothrombin gene polymorphisms with early pregnancy loss&lt;/strong&gt;</article-title><trans-title-group xml:lang="en"><trans-title>&lt;strong&gt;Association of VEGFA, factor V and prothrombin gene polymorphisms with early pregnancy loss&lt;/strong&gt;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Ahmed</surname><given-names>Abdulbary A.M.</given-names></name><name xml:lang="en"><surname>Ahmed</surname><given-names>Abdulbary A.M.</given-names></name></name-alternatives><email>bariiameen@hotmail.com</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Azova</surname><given-names>Madina M.</given-names></name><name xml:lang="en"><surname>Azova</surname><given-names>Madina M.</given-names></name></name-alternatives><email>azovam@mail.ru</email></contrib></contrib-group><pub-date pub-type="epub"><year>2021</year></pub-date><volume>7</volume><issue>2</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2021/2/Биомед_июнь-6-11.pdf" /><abstract xml:lang="ru"><p>Background:&amp;nbsp;Many studies conducted to assess the associations between the gene polymorphisms of factor V, prothrombin, and vascular endothelial growth factor gene A and recurrent early pregnancy loss (REPL) have shown conflicting findings. The aim of the study:&amp;nbsp;We designed this study and selected the most common polymorphisms that have been analyzed before, VEGFA &amp;minus;2578C/A (rs699947), VEGFA 936C/T (rs3025039), FVL G1691A (rs6025), and prothrombin FII G20210A (rs1799963) to be the candidate genetic polymorphisms for analysis of their association with idiopathic early pregnancy loss in Russian women. Materials and methods:&amp;nbsp;100 women with idiopathic early pregnancy loss were enrolled and classified into two subgroups: sporadic early pregnancy loss (SEPL), consisting of 50 women, and recurrent early pregnancy loss (REPL), consisting of 50 women. The control group included 56 women with full-term babies. Genotyping was performed using commercially available kits (Syntol, Russia) for Real time-PCR method. Genotype and allele distributions in studied groups were compared using the chi-square test and Fisher&amp;rsquo;s exact test. The tests and calculation of Odds ratio with 95% confidence intervals (CIs) were conducted employing the statistical software SPSS, version 22. Results:&amp;nbsp;The heterozygous genotype (CA) for VEGFA rs699947 was significantly associated with REPL. Findings have shown that women carrying the heterozygous genotype had a higher REPL risk (OR 9.04, 95% CI 4.33-18.7). No significant associations with SEPL or REPL were found for the other studied polymorphisms. Conclusion:&amp;nbsp;Our findings suggest that heterozygosity for VEGFA rs699947 gene polymorphism may play a role in predisposition to idiopathic early pregnancy loss and can be a genetic risk factor for recurrent early miscarriage in Russian women. </p></abstract><trans-abstract xml:lang="en"><p>Background:&amp;nbsp;Many studies conducted to assess the associations between the gene polymorphisms of factor V, prothrombin, and vascular endothelial growth factor gene A and recurrent early pregnancy loss (REPL) have shown conflicting findings. The aim of the study:&amp;nbsp;We designed this study and selected the most common polymorphisms that have been analyzed before, VEGFA &amp;minus;2578C/A (rs699947), VEGFA 936C/T (rs3025039), FVL G1691A (rs6025), and prothrombin FII G20210A (rs1799963) to be the candidate genetic polymorphisms for analysis of their association with idiopathic early pregnancy loss in Russian women. Materials and methods:&amp;nbsp;100 women with idiopathic early pregnancy loss were enrolled and classified into two subgroups: sporadic early pregnancy loss (SEPL), consisting of 50 women, and recurrent early pregnancy loss (REPL), consisting of 50 women. The control group included 56 women with full-term babies. Genotyping was performed using commercially available kits (Syntol, Russia) for Real time-PCR method. Genotype and allele distributions in studied groups were compared using the chi-square test and Fisher&amp;rsquo;s exact test. The tests and calculation of Odds ratio with 95% confidence intervals (CIs) were conducted employing the statistical software SPSS, version 22. Results:&amp;nbsp;The heterozygous genotype (CA) for VEGFA rs699947 was significantly associated with REPL. Findings have shown that women carrying the heterozygous genotype had a higher REPL risk (OR 9.04, 95% CI 4.33-18.7). No significant associations with SEPL or REPL were found for the other studied polymorphisms. Conclusion:&amp;nbsp;Our findings suggest that heterozygosity for VEGFA rs699947 gene polymorphism may play a role in predisposition to idiopathic early pregnancy loss and can be a genetic risk factor for recurrent early miscarriage in Russian women. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>recurrent pregnancy loss</kwd><kwd>VEGFA</kwd><kwd>factor V</kwd><kwd>prothrombin</kwd><kwd>gene polymorphisms</kwd></kwd-group><kwd-group xml:lang="en"><kwd>recurrent pregnancy loss</kwd><kwd>VEGFA</kwd><kwd>factor V</kwd><kwd>prothrombin</kwd><kwd>gene polymorphisms</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>ACOG Practice Bulletin No. 200: Early Pregnancy Loss. Obstetrics and Gynecology. 2018;132(5):e197-e207. DOI:&amp;nbsp;https://doi.org/10.1097/aog.0000000000002899&amp;nbsp;</mixed-citation></ref><ref id="B2"><mixed-citation>Bashiri A, Borick JL. Recurrent pregnancy loss: definitions, epidemiology, and prognosis. In: Bashiri A, Harlev A, Agarwal A, editors. Recurrent pregnancy loss: evidence-based evaluation, diagnosis and treatment. Heidelberg: Springer; 2016. DOI:&amp;nbsp;https://doi.org/10.1007/978-3-319-27452-2_1</mixed-citation></ref><ref id="B3"><mixed-citation>Diejomaoh MFE. Recurrent Spontaneous Miscarriage Is Still a Challenging Diagnostic and Therapeutic Quagmire. Medical Principles and Practice. 2015;24:(suppl1):38-55. DOI: https://doi.org/10.1159/000365973&amp;nbsp;</mixed-citation></ref><ref id="B4"><mixed-citation>Liatsikos SA, Tsikouras P, Manav B, et al. Inherited thrombophilia and reproductive disorders. Journal of the Turkish-German Gynecological Association. 2016;17(1):45-50. DOI: https://doi.org /10.5152/jtgga.2016.15212</mixed-citation></ref><ref id="B5"><mixed-citation>Yalcintepe S, Ozdemir O, Hacivelioglu SO, et al. Multiple Inherited Thrombophilic Gene Polymorphisms in Spontaneous Abortions in Turkish Population. International Journal of Molecular and Cellular Medicine. 2015;4(2):121-127.</mixed-citation></ref><ref id="B6"><mixed-citation>Andersen NF, Vogel U, Klausen TW, et al. Vascular endothelial growth factor (VEGF) gene polymorphisms may influence the efficacy of thalidomide in multiple myeloma. International Journal of Cancer. 2012;131(5):E636-E642. DOI: https://doi.org/10.1002/ijc.27387</mixed-citation></ref><ref id="B7"><mixed-citation>Sun Y, Chen M, Mao B, et al. Association between vascular endothelial growth factor polymorphism and recurrent pregnancy loss: A systematic review and meta-analysis. European Journal of Obstetrics, Gynecology and Reproductive Biology. 2017;211:169-176. DOI: https://doi.org /10.1016/j.ejogrb.2017.03.003</mixed-citation></ref><ref id="B8"><mixed-citation>Şamli H, Demir B&amp;Ccedil;, &amp;Ouml;zg&amp;ouml;z A, et al. Vascular endothelial growth factor gene 1154 G/A, 2578 C/A, 460 C/T, 936 C/T polymorphisms and association with recurrent pregnancy losses. Genetics and Molecular Research. 2012;11(4):4739-4745. DOI: https://doi.org/10.4238/2012.december.17.6</mixed-citation></ref><ref id="B9"><mixed-citation>Eller AG, Branch DW, Nelson L, et al.Journal of Reproductive Immunology. 2011;88(1):48-52. DOI: https://doi.org/10.1016/j.jri.2010.06.159</mixed-citation></ref><ref id="B10"><mixed-citation>Luo L, Li D, Wei S, et al. Polymorphisms in the vascular endothelial growth factor gene associated with recurrent spontaneous miscarriage. Journal of Maternal-Fetal and Neonatal Medicine. 2013;26(7):686-690. DOI: https://doi.org/10.3109/14767058.2012.746305</mixed-citation></ref><ref id="B11"><mixed-citation>Xu X, Du C, Li H, et al. Association of VEGF Genetic Polymorphisms with Recurrent Spontaneous Abortion Risk: A Systematic Review and Meta-Analysis. PLoS ONE. 2015;10(4):e0123696. DOI: https://doi.org/10.1371/journal.pone.0123696&amp;nbsp;</mixed-citation></ref><ref id="B12"><mixed-citation>Marakhovskaya TA, Butenko EV, Kovalenko KA, et al. Association of Growth Factors Genes with Miscarriage. Journal of Reproduction and Infertility. 2018;19(4):219-228.</mixed-citation></ref></ref-list></back></article>